Cost Considerations in Patient-Controlled Analgesia Ada JacoxDaniel B. CarrBetty M. Ferrell Leading Article 15 November 2012 Pages: 109 - 120
The Use of Consensus Methods and Expert Panels in Pharmacoeconomic Studies Christopher Evans Leading Article 15 November 2012 Pages: 121 - 129
Cost-Related Information to be Provided by Computerised Drug-Prescription Systems to Promote Cost-Effective Prescribing Claudine MilsteinAlain Venot Review Article 15 November 2012 Pages: 130 - 139
A Review of Quality of Life in Chronic Renal Failure Darren S. ParsonsDavid C. H. Harris Review Article 15 November 2012 Pages: 140 - 160
The Cost Effectiveness of Pneumococcal Vaccination Strategies Carol B. GableMarc BottemanKaren Joy Review Article 15 November 2012 Pages: 161 - 174
Economic Impact of Digoxin Toxicity Ashesh J. GandhiPeter H. VlassesJerry L. Bauman Original Research Article 15 November 2012 Pages: 175 - 181
An Economic Analysis of the Survival and Ventricular Enlargement (SAVE) Study Sylvia HummelJames PiercyJohn McMurray Original Research Article 15 November 2012 Pages: 182 - 192
Prednicarbate versus Fluocortin for Inflammatory Dermatoses Adolfo Ga de TiedraJoan MercadalRafael Lozano Original Research Article 15 November 2012 Pages: 193 - 208
Ganciclovir Caroline M. PerryRick Davis Adis Pharmacoeconomic Drug Evaluation 15 November 2012 Pages: 209 - 228
Comments on Economic Evaluation of Chemotherapy Simon R. ClausenViggo JønssonSteen W. Hansen Correspondence 15 November 2012 Pages: 229 - 231